These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 6542462

  • 1. Beneficial effect of a thromboxane synthetase inhibitor in traumatic shock.
    Hock CE, Lefer AM.
    Circ Shock; 1984; 14(3):159-68. PubMed ID: 6542462
    [Abstract] [Full Text] [Related]

  • 2. Protective effects of a combination thromboxane synthesis inhibitor-receptor antagonist, R-68070, during murine traumatic shock.
    Aoki N, Johnson G, Siegfried MR, Lefer AM.
    Eicosanoids; 1989; 2(3):169-74. PubMed ID: 2534278
    [Abstract] [Full Text] [Related]

  • 3. Beneficial actions of BN 50739, a new PAF receptor antagonist, in murine traumatic shock.
    Karasawa A, Rochester JA, Lefer AM.
    Methods Find Exp Clin Pharmacol; 1990 May; 12(4):231-7. PubMed ID: 2165204
    [Abstract] [Full Text] [Related]

  • 4. Protective effects of a new LTD4 antagonist (LY-171883) in traumatic shock.
    Hock CE, Lefer AM.
    Circ Shock; 1985 May; 17(4):263-72. PubMed ID: 3841503
    [Abstract] [Full Text] [Related]

  • 5. Use of the novel cardiotonic and vasodilator agent pimobendan in traumatic shock.
    Bitterman H, Smith BA, Lefer AM.
    Arzneimittelforschung; 1988 Oct; 38(10):1389-93. PubMed ID: 3196378
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of two leukotriene antagonists in rat traumatic shock.
    Levitt MA, Lefer AM.
    Methods Find Exp Clin Pharmacol; 1987 May; 9(5):269-73. PubMed ID: 3613754
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Potentiation of the protective effects of a converting enzyme inhibitor and a thromboxane synthetase inhibitor in hemorrhagic shock.
    Bitterman H, Phillips GR, Dragon G, Lefer AM.
    J Pharmacol Exp Ther; 1987 Jul; 242(1):8-14. PubMed ID: 3039116
    [Abstract] [Full Text] [Related]

  • 9. Protective effects of KW-3635, a novel thromboxane A2 antagonist, in murine traumatic shock.
    Karasawa A, Taylor PA, Lefer AM.
    Eur J Pharmacol; 1990 Jun 21; 182(1):1-8. PubMed ID: 2401310
    [Abstract] [Full Text] [Related]

  • 10. Salutary effects of anisodamine in murine traumatic shock.
    Hock CE, Su JY, Lefer AM.
    Circ Shock; 1983 Jun 21; 11(3):211-6. PubMed ID: 6652878
    [Abstract] [Full Text] [Related]

  • 11. Reduced myocardial neutrophil accumulation and infarct size following thromboxane synthetase inhibitor or receptor antagonist.
    Nichols WW, Mehta J, Wargovich TJ, Franzini D, Lawson D.
    Angiology; 1989 Mar 21; 40(3):209-21. PubMed ID: 2537051
    [Abstract] [Full Text] [Related]

  • 12. Beneficial actions of antagonism of peptide leukotrienes in hemorrhagic shock.
    Bitterman H, Smith BA, Lefer AM.
    Circ Shock; 1988 Mar 21; 24(3):159-68. PubMed ID: 3383353
    [Abstract] [Full Text] [Related]

  • 13. Protective actions of aprotinin in acute traumatic shock.
    Araki H, Lefer AM.
    Arch Int Pharmacodyn Ther; 1979 Oct 21; 241(2):316-23. PubMed ID: 316692
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of a combination thromboxane receptor antagonist and lipoxygenase inhibitor in traumatic shock.
    Levitt MA, Stahl G, Lefer AM.
    Resuscitation; 1988 Jul 21; 16(3):211-20. PubMed ID: 2845544
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Beneficial effects of U-63,557A, a thromboxane synthetase inhibitor, in an ovine model of pregnancy-induced hypertension.
    Keith JC, Thatcher CD, Schaub RG.
    Am J Obstet Gynecol; 1987 Jul 21; 157(1):199-203. PubMed ID: 3605254
    [Abstract] [Full Text] [Related]

  • 19. Beneficial effects of a neutral protease inhibitor in traumatic shock.
    Hock CE, Lefer AM.
    Pharmacol Res Commun; 1985 Mar 21; 17(3):217-26. PubMed ID: 4011646
    [Abstract] [Full Text] [Related]

  • 20. Prevention of endotoxin-induced pulmonary hypertension in primates by the use of a selective thromboxane synthetase inhibitor, OKY 1581.
    Casey LC, Fletcher JR, Zmudka MI, Ramwell PW.
    J Pharmacol Exp Ther; 1982 Aug 21; 222(2):441-6. PubMed ID: 6896528
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.